Acute coronary syndrome (ACS) continues to be a substantial contributor to both morbidity and mortality, withstanding notable evolutions in its prevention and treatment. (1).
Hypercholesterolemia is a known significant risk factor for coronary artery disease. Increased total cholesterol, LDL cholesterol (LDL-C), and non-HDL-Cholesterol (non-HDL-C) are associated with 20 – 30% risk of premature cardiac damage in youth. Hypertriglyceridemia is associated with two-threefold risk of incident and progressive cardiac and structural damage. (1) Lipid-lowering therapy must be initiated immediately after ACS to reduce the risk of recurrent cardiovascular events and mortality. (2) The approach to managing hypercholesterolemia has evolved significantly over the years, emphasizing the need for an aggressive treatment, akin to firing at a target, while also highlighting the importance of long-term vigilance.
Author Sub-editor: Dr May Hu Dr May Hu is a cardiology trainee in the North West deanery. She graduated with First Class Honours from the University
Author Sub-editor: Dr Jhiamluka Solano Dr Jhiamluka Solano is a cardiology resident doctor (ST6) in the Yorkshire and Humber Deanery, currently undertaking a DPhil (PhD)
Author Sub-editor: Dr Justin Chiong Dr Justin Chiong is an NIHR Academic Clinical Fellow and Cardiology Registrar in the North West Deanery. He graduated from
Author Heartbeat Sub-Editor: Marina Zafeiri Dr Marina Zafeiri is an IMT3 in the Wessex deanery, with a strong interest in Cardiology. She graduated from Athens
Author Heartbeat Sub-Editor: Toby MacCarthy Author: Toby MacCarthy
Author Heartbeat Sub-Editor: Toby MacCarthy Author: Toby MacCarthy
